Does paclitaxel (Taxol) given after ¹¹¹In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?MIERS, Laird; LAMBORN, Kathleen; YUAN, Aina et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 7158s-7163s, issn 1078-0432, 2Conference Paper

Doxorubicin induces specific immune functions and cytokine expression in peritoneal cellsUJHAZY, Peter; ZALESKIS, Gintaras; MIHICH, Enrico et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 7, pp 463-472, issn 0340-7004, 10 p.Article

Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-β and retinoic acid on monocytic and granulocytic differentiation of HL-60 cellsZHOUHONG CAO; FLANDERS, Kathleen C; BERTOLETTE, Daniel et al.Blood. 2003, Vol 101, Num 2, pp 498-507, issn 0006-4971, 10 p.Article

Adding interferon-α to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumoursPAPE, Ulrich-Frank; WIEDENMANN, Bertram.Cancer treatment reviews. 2003, Vol 29, Num 6, pp 565-569, issn 0305-7372, 5 p.Article

Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapyMEUNIER, Marie-Christine; ROY-PROULX, Guillaume; LABRECQUE, Nathalie et al.Blood. 2003, Vol 101, Num 2, pp 766-770, issn 0006-4971, 5 p.Article

Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer modelBUCHSBAUM, Donald J; TONG ZHOU; GRIZZLE, William E et al.Clinical cancer research. 2003, Vol 9, Num 10, pp 3731-3741, issn 1078-0432, 11 p., 1Article

Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: Metaanalytic reevaluationHUNCHAREK, Michael; KUPELNICK, Bruce.American journal of clinical oncology. 2003, Vol 26, Num 4, pp 402-407, issn 0277-3732, 6 p.Article

Therapy with ¹⁸⁸re-labeled radiopharmaceuticals: An overview of promising results from initial clinical trialsJAE MIN JEONG; CHUNG, June-Key.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 5, pp 707-717, issn 1084-9785, 11 p.Article

Targeted therapy and pharmacogenomic programsIQBAL, Syma; LENZ, Heinz Josef.Cancer. 2003, Vol 97, Num 8, pp 2076-2082, issn 0008-543X, 7 p., SUPConference Paper

Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistanceMUKANGANYAMA, Stanley; WIDERSTEN, Mikael; NAIK, Yogeshkumar S et al.International journal of cancer. 2002, Vol 97, Num 5, pp 700-705, issn 0020-7136Article

Premenopausal breast cancer: Chemotherapy and endocrine therapySAYER, Herbert G; KATH, Roland; KLICHE, Kay-Oliver et al.Drugs (Basel). 2002, Vol 62, Num 14, pp 2025-2038, issn 0012-6667, 14 p.Article

Isolated limb perfusion in locally advanced cutaneous melanomaROSSI, Carlo Riccardo; FOLETTO, Mirto; PILATI, Pierluigi et al.Seminars in oncology. 2002, Vol 29, Num 4, pp 400-409, issn 0093-7754Article

Epidermal growth factor receptor-targeted therapy in colorectal cancerO'DWYER, Peter J; BENSON, Al B.Seminars in oncology. 2002, Vol 29, Num 5, pp 10-17, issn 0093-7754, SUP14Conference Paper

Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancerBUNN, Paul A; FRANKLIN, Wilbur.Seminars in oncology. 2002, Vol 29, Num 5, pp 38-44, issn 0093-7754, SUP14Conference Paper

Medical management of patients with refractory carcinoma in situ of the bladderKIM, James C; STEINBERG, Gary D.Drugs & aging. 2001, Vol 18, Num 5, pp 335-344, issn 1170-229XArticle

Adeno-associated virus for cancer gene therapyPONNAZHAGAN, Selvarangan; CURIEL, David T; SHAW, Denise R et al.Cancer research (Baltimore). 2001, Vol 61, Num 17, pp 6313-6321, issn 0008-5472Article

New treatment possibilities for pancreatic and biliary tumoursVAN CUTSEM, Eric; HAUSTERMANS, Karin; VAN STEENBERGEN, Werner et al.Annals of oncology. 2000, Vol 11, pp 165-169, issn 0923-7534, SUP3Conference Paper

Eradication of human Non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamideKLASA, R. J; BALLY, M. B; NG, R et al.Clinical cancer research. 2000, Vol 6, Num 6, pp 2492-2500, issn 1078-0432Article

Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy : A strategy for maintaining dose intensityLOKICH, J.Cancer investigation. 1999, Vol 17, Num 7, pp 547-550, issn 0735-7907Article

Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity : A direct comparison with systemic IL-12 protein therapyRAKHMILEVICH, A. L; TIMMINS, J. G; JANSSEN, K et al.Journal of immunotherapy (1997). 1999, Vol 22, Num 2, pp 135-144, issn 1524-9557Article

On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumourSUR, P; GHOSH, P; BAG, S. P et al.Chemotherapy (Basel). 1999, Vol 45, Num 5, pp 360-369, issn 0009-3157Article

Current management of metastatic breast cancerPEREZ, E. A.Seminars in oncology. 1999, Vol 26, Num 4, pp 1-10, issn 0093-7754, SUP12Conference Paper

Pancreatic endocrine tumours, immunotherapy and gene therapy : Chemotherapy and interferon therapy of endocrine tumoursVEENHOF, C. H. N.Annals of oncology. 1999, Vol 10, pp 185-187, issn 0923-7534, SUP4Conference Paper

A case report of immunotherapy on a patient with advanced gastric cancer by adoptive transfer of OK-432-reactive HLA-matched allogeneic lymphocytesYAMAGISHI, H; UEDA, Y; OKA, T et al.Cancer immunology and immunotherapy. 1998, Vol 46, Num 2, pp 113-119, issn 0340-7004Article

Pharmacodynamic aspects of peptide administration biological response modifiersTALMADGE, J. E.Advanced drug delivery reviews. 1998, Vol 33, Num 3, pp 241-252, issn 0169-409XArticle